Bryant Henry Uhlman

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention relates to compounds of formula I I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 2-thienyl, 3-thienyl, benzothienyl, or -CH2C6H5; any of …

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention provides novel benzofuran compound, pharmaceutical formulations and processes for preparation thereof, and methods of using such compounds for alleviating the symtoms of post-menopausal syndrome, and inhibiting endomet…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention relates to compounds of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is 1-naphthyl, 2-naphthyl, 1-thienyl, 2-thienyl, benzothienyl, or -CH2C6H5; any of…

The present invention provides novel benzothiophene compounds of formula I wherein R is -H, -OH, -O(C -C alkyl), -O-CO-(C -C alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO -(C -C alkyl); R is -H, -OH, -O(C -C alkyl…